Cardiac MRI for Iron Overload in Pediatric Thalassemia Patients- Right Age to Start in a Resource Constrained Environment

Overview

Journal Indian J Hematol Blood Transfus

Specialty Hematology

Date 2022 Jun 24

PMID 35747577

Authors

Khushboo Pilania

Bhavin Jankharia

Aamish Kazi

Affiliations

Soon will be listed here.

Abstract

The aim of this article is to assess the prevalence and severity of myocardial iron overload in thalassemia patients who present for the first time for cardiac MRI and to define the right age to start screening, in a resource-constrained environment. All MRI scans done at our institute for myocardial iron overload assessment in thalassemia patients, between 2015 and 2018 were analysed. Patients up to the age of 30 years were included. There were a total of 600 patients, (Age group between 2 and 30 years). All these scans were retrospectively analysed and severity of myocardial iron overload was categorized as normal, mild, moderate and severe based on the bright blood T2* equivalent values at 1.5 T. Overall prevalence of myocardial iron overload was 32.3%, while the prevalence of myocardial iron overload in patients in the age group 0-10 was 10.2%.There were 40 patients in the age group 0-6 years, of whom, only 2 had myocardial iron overload. In patients less than or equal to 6 years of age, the number of patients with iron overload was very small and this may be used to decide the optimal age for scanning.

Citing Articles

Beta Thalassemia in Children: Established Approaches, Old Issues, New Non-Curative Therapies, and Perspectives on Healing.

Origa R, Issa L J Clin Med. 2024; 13(22).

PMID: 39598110 PMC: 11594693. DOI: 10.3390/jcm13226966.

References

Zurlo M, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C . Survival and causes of death in thalassaemia major. Lancet. 1989; 2(8653):27-30. DOI: 10.1016/s0140-6736(89)90264-x. View

Wood J . Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol. 2007; 14(3):183-90. PMC: 2892972. DOI: 10.1097/MOH.0b013e3280d2b76b. View

Wood J, Michael Tyszka J, Carson S, Nelson M, Coates T . Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease. Blood. 2003; 103(5):1934-6. DOI: 10.1182/blood-2003-06-1919. View

Storey P, Thompson A, Carqueville C, Wood J, de Freitas R, Rigsby C . R2* imaging of transfusional iron burden at 3T and comparison with 1.5T. J Magn Reson Imaging. 2007; 25(3):540-7. PMC: 2884049. DOI: 10.1002/jmri.20816. View

Alam M, Auger D, McGill L, Smith G, He T, Izgi C . Comparison of 3 T and 1.5 T for T2* magnetic resonance of tissue iron. J Cardiovasc Magn Reson. 2016; 18(1):40. PMC: 4938967. DOI: 10.1186/s12968-016-0259-9. View

Olivieri N, Nathan D, MacMillan J, Wayne A, Liu P, McGee A . Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med. 1994; 331(9):574-8. DOI: 10.1056/NEJM199409013310903. View

Angelucci E, Barosi G, Camaschella C, Cappellini M, Cazzola M, Galanello R . Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica. 2008; 93(5):741-52. DOI: 10.3324/haematol.12413. View

Westwood M, Anderson L, Firmin D, Gatehouse P, Lorenz C, Wonke B . Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemia. J Magn Reson Imaging. 2003; 18(5):616-20. DOI: 10.1002/jmri.10396. View

Anderson L, Holden S, Davis B, Prescott E, Charrier C, Bunce N . Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2002; 22(23):2171-9. DOI: 10.1053/euhj.2001.2822. View

10.

Lara Fernandes J, Fabron Jr A, Verissimo M . Early cardiac iron overload in children with transfusion-dependent anemias. Haematologica. 2009; 94(12):1776-7. PMC: 2791941. DOI: 10.3324/haematol.2009.013193. View

11.

Wood J . Use of magnetic resonance imaging to monitor iron overload. Hematol Oncol Clin North Am. 2014; 28(4):747-64, vii. PMC: 4115249. DOI: 10.1016/j.hoc.2014.04.002. View

12.

McLaren G, Muir W, KELLERMEYER R . Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci. 1983; 19(3):205-66. DOI: 10.3109/10408368309165764. View

13.

Ehlers K, Levin A, Markenson A, Marcus J, Klein A, Hilgartner M . Longitudinal study of cardiac function in thalassemia major. Ann N Y Acad Sci. 1980; 344:397-404. DOI: 10.1111/j.1749-6632.1980.tb33678.x. View

14.

Borgna-Pignatti C, Meloni A, Guerrini G, Gulino L, Filosa A, Ruffo G . Myocardial iron overload in thalassaemia major. How early to check?. Br J Haematol. 2014; 164(4):579-85. DOI: 10.1111/bjh.12643. View

15.

Ghugre N, Wood J . Relaxivity-iron calibration in hepatic iron overload: probing underlying biophysical mechanisms using a Monte Carlo model. Magn Reson Med. 2011; 65(3):837-47. PMC: 3065944. DOI: 10.1002/mrm.22657. View

16.

Casale M, Meloni A, Filosa A, Cuccia L, Caruso V, Palazzi G . Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study. Circ Cardiovasc Imaging. 2015; 8(8):e003230. DOI: 10.1161/CIRCIMAGING.115.003230. View

17.

Gordeuk V, Bacon B, Brittenham G . Iron overload: causes and consequences. Annu Rev Nutr. 1987; 7:485-508. DOI: 10.1146/annurev.nu.07.070187.002413. View

18.

Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini M, Del Vecchio G . Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004; 89(10):1187-93. View

19.

Wood J, Origa R, Agus A, Matta G, Coates T, Galanello R . Onset of cardiac iron loading in pediatric patients with thalassemia major. Haematologica. 2008; 93(6):917-20. PMC: 2892933. DOI: 10.3324/haematol.12513. View

20.

Berdoukas V, Nord A, Carson S, Puliyel M, Hofstra T, Wood J . Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age. Am J Hematol. 2013; 88(11):E283-5. DOI: 10.1002/ajh.23543. View